Pathway to Cures

Spark Biomedical develops wearable neurostimulation devices for opioid withdrawal relief. Its transcutaneous auricular neurostimulation technology stimulates nerves around the ear to alleviate withdrawal symptoms, offering a non-pharmaceutical approach to support long-term recovery.

Anvesana is a biotechnology company focused on developing therapies for inheritable blood and bleeding disorders, particularly rare genetic disorders linked to insufficient protein production. The company specializes in RNA-sequence analysis and aims to identify specific regions within genes that can be targeted to enhance gene expression. This innovative approach enables Anvesana to address conditions that currently lack approved disease-modifying therapies, offering potential solutions for patients affected by these challenging disorders. Through its research and development efforts, Anvesana seeks to make significant advancements in the treatment landscape for rare genetic diseases.